Pain and Inflammation Research
Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.
Pain and Inflammation Research Products Areas
Products for Pain and Inflammation Research - Page 33
- Cat.No. Product Name Information/Activity
-
BCC2362
SID 26681509
SID 26681509 is a potent, reversible, competitive, and selective inhibitor of human cathepsin L with an IC50 of 56 nM. SID 26681509 inhibits in vitro propagation of malaria parasite Plasmodium falciparum and inhibits Leishmania major with IC50s of 15.4 μM and 12.5 μM, respectively. SID 26681509 shows no inhibitory activity against cathepsin G.
-
BCC8039
PMX 205
PMX 205 is a potent complement C5a receptor (C5aR; CD88) antagonist.
-
BCC6067
Compstatin control peptide
301544-78-5
-
BCC7886
BTZO 1
BTZO-1 binds to Macrophage migration inhibitory factor (MIF) with a Kd value of 68.6 nM, and its binding requires the N-terminal Pro1. BTZO-1 can activate antioxidant response element (ARE)-mediated gene expression and suppress oxidative stress-induced cardiomyocyte apoptosis in vitro.
-
BCC6816
Chicago Sky Blue 6B
2610-05-1
-
BCC6161
(±)-CPSI 1306
(±)-CPSI-1306 is an orally available antagonist of macrophage migration inhibitory factor (MIF).
-
BCC5914
ER 27319 maleate
1204480-26-1
-
BCC2096
Gabexate mesylate
Gabexate mesylate is a Factor X inhibitor; serine protease inhibitor .
-
BCC5203
VGX-1027
VGX-1027(GIT27) is an isoxazole compound that exhibits various immunomodulatory properties; reduce the secretion of IL-1beta, TNF-alpha and IL-10 from purified murine macrophages.
-
BCC6365
iMDK
881970-80-5


